Yosuke Kawashima

Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer

Yukihiro Toi, Shunichi Sugawara, Jun Sugisaka et al. · JAMA Oncology · 2018 · 360 citations · Full text

Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab

Yukihiro Toi, Shunichi Sugawara, Yosuke Kawashima et al. · The Oncologist · 2018 · 289 citations · Full text

First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon <i>EGFR</i> Mutations

Yusuke Okuma, Kaoru Kubota, Mototsugu Shimokawa et al. · JAMA Oncology · 2023 · 67 citations · Full text

Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung Cancer

Mari Aso, Yukihiro Toi, Jun Sugisaka et al. · The Oncologist · 2019 · 56 citations · Full text

Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with Pembrolizumab

Jun Sugisaka, Yukihiro Toi, Masataka Taguri et al. · JMA Journal · 2019 · 26 citations · Full text